MeiraGTx

QC Stability Manager

MeiraGTx  •  London, GB (Onsite)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Your mission

The Stability Manager is responsible for managing all aspects of the stability program across all projects and UK and Ireland sites, including initiating and managing stability studies, protocol development and maintenance, data monitoring, trending and reporting.

Major Activities

  • Designs, coordinate, and execute stability studies for clinical and commercial gene therapy products according to regulatory guidelines and company protocols.
  • Generate stability reports by applying analytical testing expertise to ensure scientific and technical excellence. Utilize statistical software like JMP to perform rigorous statistical analyses, ensuring robust interpretation of data and adherence to regulatory standards.
  • Authors, reviews, revises, and approves SOP's, stability protocols and reports, memo’s, regulatory and specification documents (as required).
  • The Stability Manager will also assist with leading the functionality and maintenance of stability related processes and systems.
  • Drives continuous improvement activities for the stability programs.
  • Ensures that the GMP stability program continuously aligns with FDA, ICH and other international agencies.
  • Manages Quality Systems records for QC Stability- creates, assesses, reviews Deviations, Change Controls, CAPA's and other applicable stability-related investigations and events.
  • Guide and work with others to identify opportunities for continuous improvement and implement/maintain solutions.
  • Provide strong teamwork in establishing a quality culture and shared accountability. Ensure GMP compliance is built into the design and implementation of processes and systems, including tracking metrics to monitor and improve performance.
  • Responsible for ensuring that own work and that of the team complies with GMP, Data Integrity and Good Documentation Practice (GDP) and is undertaken in accordance with applicable procedures
  • Responsible for ensuring that own training and that of the team is undertaken in a timely and GMP compliant manner before the task is undertaken.
  • Responsible for ensuring that any GMP documentation e.g. (but not limited to) Issues, CAPAs, Change Controls, BMRs & audit/inspection actions, within own area of responsibility, is closed timely and in a RFT state.


Job Background

  • 5 years of relevant industry experience in Pharma / Biotech industry required.
  • Strong understanding of gene therapy stability principles, including degradation pathways, accelerated stability testing, and shelf-life determination.
  • Proven experience in managing staff.
  • Demonstrated proficiency and expertise in various analytical methodologies, particularly in the context of stability testing and assessment of biologics or gene therapy.
  • Solid understanding of relevant FDA, EU, and ICH regulatory guidelines and pharmacopeia as applicable to stability study design, expiry dating, and analytical method qualification/validation for biologics and gene therapy.
  • Solid understanding and hands-on experience of applying basic statistical tools for stability data trending and rate analysis to support retest period/ shelf-life proposals.
  • Attention to detail and excellent skills in record keeping / documentation.
  • Experience in IND, NDA and BLA submission is highly preferred.
  • Strong interpersonal skills; ability to communicate effectively both verbally and in written formats.
  • Solid understanding of product development activities in biotech/drug/gene therapy development, including key interdependencies, and knowledge of proven development strategies and tactics.
  • To travel to other Meira sites when required.
MeiraGTx

About MeiraGTx

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicine company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities. MeiraGTx has an internally developed manufacturing platform process, internal plasmid production for GMP, two GMP viral vector production facilities as well as an in-house Quality Control hub for stability and release, all fit for IND through commercial supply. MeiraGTx has core capabilities in viral vector design and optimization and a potentially transformative riboswitch gene regulation platform technology that allows for the precise, dose-responsive control of gene expression by oral small molecules. MeiraGTx is focusing the riboswitch platform on delivery of metabolic peptides including GLP-1, GIP, Glucagon and PYY using oral small molecules, as well as cell therapy for oncology and autoimmune diseases. Although initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx has developed the technology to apply genetic medicine to more common diseases, increasing efficacy, addressing novel targets, and expanding access in some of the largest disease areas where the unmet need remains great.

Industry
Unknown
Company Size
201-500 employees
Headquarters
London/New York, GB
Year Founded
2015
Social Media